Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 9069

Case report
Table of Contents - Year : 2018 | Month : July | Volume : 12 | Issue : 7 | Page : ND01 - ND03

Effective Treatment of Epithelial Downgrowth in Persistent Wound Leak Following Removal of Silicone Oil ND01-ND03

Mae-Lynn Catherine Bastion, Kong Yong Then, Aida Mohd Zahidin

Correspondence
Dr. Mae-Lynn Catherine Bastion,
Professor, Department of Ophthalmology, Faculty of Medicine, UKM Medical Centre,
Jalan Yaacob Latif-56000, Kuala Lumpur, Malaysia.
E-mail: mae-lynn@ppukm.ukm.edu.my

This case report aims to share the successful management of Epithelial Downgrowth (ED) which occurred following persistent wound leak, after Removal of Silicone Oil (ROSO) via the anterior chamber. A teenage male with history of high myopia underwent bilateral phacoemulsification and implantation of Multifocal Intraocular Lens (MFIOLs). Four months later, he complained of left eye floaters and blurring of vision. Fundus showed left vitreous haemorrhage with lens subluxation. Left 23 gauge pars plana vitrectomy revealed multiple retinal tears. Endolaser and gas injection with MFIOL repositioning was done. Retinal redetachment and MFIOL subluxation occurred six weeks postoperatively. Revision vitrectomy with silicone oil and explantation of MFIOL was performed rendering left eye aphakic. Four months later, he underwent ROSO via a superior corneal incision. Positive Seidels was seen two weeks post-ROSO and resuturing was performed. Unfortunately, advancing ED was noted at the superior cornea. One month after ROSO, scleral fixated IOL implantation with manual removal of ED and intracameral injection of 5-fluorouracil (5-FU) were performed. Twelve months postoperatively, cornea remained clear with a pinhole vision of 6/7.5 and retina was flat. In conclusion, wound leak after ROSO via the anterior chamber in aphakic individuals may predispose to ED. Key to treatment of this sight threatening condition is thoughtful anterior segment examination. Manual removal of the membrane combined with 5-FU injection during secondary lens implantation surgery is an effective treatment.